ROBERT SHUPE: Open Payments
NPI 1811272297 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 145 payments from 17 companies in 2025. Trend: 2023 $1,830 · 2024 $2,286 · 2025 $2,299
Food & beverage: $2,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $376 |
| Corium, LLC | 19 | $353 |
| Axsome Therapeutics, Inc. | 13 | $241 |
| Otsuka America Pharmaceutical, Inc. | 16 | $222 |
| Lundbeck LLC | 11 | $206 |
| Tris Pharma Inc | 15 | $151 |
| Vanda Pharmaceuticals Inc. | 7 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $120 |
| Alkermes, Inc. | 6 | $119 |
| Supernus Pharmaceuticals, Inc. | 5 | $108 |
Products named: VRAYLAR, Azstarys, REXULTI, Auvelity, Dyanavel XR, FANAPT, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across AZ — which companies pay providers there.
